The Federal Trade Commission has voted to approve Valeant's acquisitions of Dermik, a unit of French drug maker Sanofi that makes drugs for skin conditions, and Ortho Dermatologics, a division of Johnson & Johnson that also makes skin drugs.
The Department of Health and Human Services on Monday announced that the first U.S. facility to use a faster and more flexible technology to make influenza vaccine was dedicated as part of an initiative that could provide vaccine supplies sooner in an influenza pandemic.
The unemployed and underemployed have limited access to health care and, in many cases, are putting off seeking medical care, according to the "Long-Term Unemployed Survey" released on Monday by NPR News and the Kaiser Family Foundation.
Though they've been on the market for less than a month, the generic and authorized generic versions of Pfizer's cholesterol-lowering drug Lipitor have captured more than one-tenth of prescriptions, according to published reports.
The Healthcare Distribution Management Association on Tuesday honored Sen. Pat Roberts, R-Kan., with its Rx Safety and Healthcare Leadership Award. The award recognizes public officials for their leadership and commitment to public policies that support and promote the safe and efficient delivery of medicines.
United Health Foundation’s "2011 America’s Heath Rankings," released Tuesday, found that increases in obesity, diabetes and children in poverty are offsetting improvements in smoking cessation, preventable hospitalizations and cardiovascular deaths.
Israel's Taro Pharmaceutical Industries has formed a special committee to review an offer by India's Sun Pharmaceutical Industries for all of the issues of Taro that Sun doesn't already own, Taro said.
As many as 111 million Americans had gotten a flu shot by mid-November, representing 36% of the 305 million Americans over the age of 6 months, the Centers for Disease Control and Prevention stated in a media telebriefing Monday afternoon.
Senior Walmart executives regularly invoke the name of Sam Walton when it serves to reinforce a point regarding the company’s business model or the cultural principles on which Walton is said to have founded the company.
Following the settlement of a patent-litigation suit with Swiss drug maker Novartis over the patch Vivelle-Dot (estradiol transdermal system), a drug for treating symptoms of menopause, Mylan said it had received a patent license to begin selling its version of the drug in December 2013.
Six retailers on Wednesday filed suit naming Wyeth and Teva Pharmaceuticals as defendants and alleging that the defendants unlawfully delayed the entry of generic versions of Wyeth's antidepressant Effexor XR (venlafaxine).